Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
Biotech
Healthcare
Therapeutics
Drug discovery
Oncology
About
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistDetails
Status
Active
Stage
Early
Team Size
5
Regions
United States of America, America / Canada